Gene · 3984
Papers2,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cofilin Acts as a Booster for Progression of Malignant Tumors Represented by Glioma. | Cancer Manag Res | 2022 | 36452435 | PubTator, text mining | PubMed |
| Myofibroblast specific targeting approaches to improve fibrosis treatment. | Chem Commun (Camb) | 2022 | 36445310 | PubTator, text mining | PubMed |
| Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (BCR::ABL+) Acute Lymphoblastic Leukemia (ALL). | J Clin Med | 2022 | 36431240 | PubTator, text mining | PubMed |
| Rho family GTPase signaling through type II p21-activated kinases. | Cell Mol Life Sci | 2022 | 36401658 | PubTator, text mining | PubMed |
| Recent advances on small molecules in osteogenic differentiation of stem cells and the underlying signaling pathways. | Stem Cell Res Ther | 2022 | 36371202 | PubTator, text mining | PubMed |
| Non-Muscle MLCK Contributes to Endothelial Cell Hyper-Proliferation through the ERK Pathway as a Mechanism for Vascular Remodeling in Pulmonary Hypertension. | Int J Mol Sci | 2022 | 36362426 | PubTator, text mining | PubMed |
| Emerging Role of YAP and the Hippo Pathway in Prostate Cancer. | Biomedicines | 2022 | 36359354 | PubTator, text mining | PubMed |
| Modulation of Cytoskeleton, Protein Trafficking, and Signaling Pathways by Metabolites from Cucurbitaceae, Ericaceae, and Rosaceae Plant Families. | Pharmaceuticals (Basel) | 2022 | 36355554 | PubTator, text mining | PubMed |
| Cytoskeletal and Cytoskeleton-Associated Proteins: Key Regulators of Cancer Stem Cell Properties. | Pharmaceuticals (Basel) | 2022 | 36355541 | PubTator, text mining | PubMed |
| Role of protein phosphorylation in cell signaling, disease, and the intervention therapy. | MedComm (2020) | 2022 | 36349142 | PubTator, text mining | PubMed |
| RHO GTPase family in hepatocellular carcinoma. | Exp Hematol Oncol | 2022 | 36348464 | PubTator, text mining | PubMed |
| A meta-analysis indicates that the regulation of cell motility is a non-intrinsic function of chemoattractant receptors that is governed independently of directional sensing. | Front Immunol | 2022 | 36341452 | PubTator, text mining | PubMed |
| Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes. | Front Immunol | 2022 | 36341390 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| The genus Porana (Convolvulaceae) - A phytochemical and pharmacological review. | Front Pharmacol | 2022 | 36330088 | PubTator, text mining | PubMed |
| Depletion of ALMS1 affects TGF-β signalling pathway and downstream processes such as cell migration and adhesion capacity. | Front Mol Biosci | 2022 | 36325276 | PubTator, text mining | PubMed |
| The phosphorylation level of Cofilin-1 is related to the pathological subtypes of gastric cancer. | Medicine (Baltimore) | 2022 | 36316865 | PubTator, text mining | PubMed |
| Recent progress on the role of non-coding RNA in postoperative cognitive dysfunction. | Front Cell Neurosci | 2022 | 36313620 | PubTator, text mining | PubMed |
| H-TEX-mediated signaling between hepatocellular carcinoma cells and macrophages and exosome-targeted therapy for hepatocellular carcinoma. | Front Immunol | 2022 | 36311698 | PubTator, text mining | PubMed |
| LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. | Eur J Med Res | 2022 | 36307879 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3984/papers?page=19